(Bloomberg) — Gilead Sciences Inc. shares climbed in late trading Thursday after a report that a group of patients being treated in Chicago were “seeing rapid recoveries in fever and respiratory symptoms.”The report, from the medical news publication Stat, cited a video made by a researcher at the University of Chicago who is helping conduct a trial of Gilead’s drug remdesivir. The researcher, infectious disease professor Kathleen Mullane, said that most patients had been discharged from the hospital and only two had died, according to Stat. Gilead’s drug is one of the most-watched therapies being studied for treatment of Covid-19 …read more
Source:: Yahoo Finance
